Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 study)
Zoltán Vokó, Zoltán Kiss, György Surján, Orsolya Surján, Zsófia Barcza, István Wittmann, Gergő Attila Molnár, Dávid Nagy, Veronika Müller, Krisztina Bogos, Péter Nagy, István Kenessey, András Wéber, Lőrinc Polivka, Mihály Pálosi, János Szlávik, György Rokszin, Cecília Müller, Zoltán Szekanecz, Miklós Kásler
doi: https://doi.org/10.1101/2022.04.14.22273898
Zoltán Vokó
1Center for Health Technology Assessment, Semmelweis University, Budapest
2Syreon Research Institute, Budapest, Hungary
Zoltán Kiss
3Second Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, Pécs, Hungary
György Surján
4Ministry of Human Resources, Budapest, Hungary
5Institute of Digital Health Sciences, Semmelweis University, Budapest
Orsolya Surján
6Department of Deputy Chief Medical Officer II., National Public Health Center, Budapest, Hungary
Zsófia Barcza
7Syntesia Medical Communications Ltd., Budapest, Hungary
István Wittmann
3Second Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, Pécs, Hungary
Gergő Attila Molnár
3Second Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, Pécs, Hungary
Dávid Nagy
1Center for Health Technology Assessment, Semmelweis University, Budapest
2Syreon Research Institute, Budapest, Hungary
Veronika Müller
8Department of Pulmonology, Semmelweis University, Budapest, Hungary
Krisztina Bogos
9Department of Pulmonology, National Korányi Institute of Pulmonology, Budapest, Hungary
Péter Nagy
10National Institute of Oncology, Budapest, Hungary
11Institute of Oncochemistry, University of Debrecen, 4012 Debrecen, Hungary
István Kenessey
10National Institute of Oncology, Budapest, Hungary
12Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary
András Wéber
10National Institute of Oncology, Budapest, Hungary
13Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France
Lőrinc Polivka
8Department of Pulmonology, Semmelweis University, Budapest, Hungary
Mihály Pálosi
15National Health Insurance Fund, Budapest, Hungary
János Szlávik
16South-Pest Hospital Centre – National Institute for Infectology and Haematology, Budapest, Hungary
György Rokszin
3Second Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, Pécs, Hungary
17RxTarget Ltd., Szolnok, Hungary
Cecília Müller
18Department of Chief Medical Officer, National Public Health Center, Budapest, Hungary
Zoltán Szekanecz
19Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
Miklós Kásler
4Ministry of Human Resources, Budapest, Hungary
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The datasets generated for this study can be found in the MedRxiv repository. Further inquiries can be directed to the corresponding author.
Posted April 18, 2022.
Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 study)
Zoltán Vokó, Zoltán Kiss, György Surján, Orsolya Surján, Zsófia Barcza, István Wittmann, Gergő Attila Molnár, Dávid Nagy, Veronika Müller, Krisztina Bogos, Péter Nagy, István Kenessey, András Wéber, Lőrinc Polivka, Mihály Pálosi, János Szlávik, György Rokszin, Cecília Müller, Zoltán Szekanecz, Miklós Kásler
medRxiv 2022.04.14.22273898; doi: https://doi.org/10.1101/2022.04.14.22273898
Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 study)
Zoltán Vokó, Zoltán Kiss, György Surján, Orsolya Surján, Zsófia Barcza, István Wittmann, Gergő Attila Molnár, Dávid Nagy, Veronika Müller, Krisztina Bogos, Péter Nagy, István Kenessey, András Wéber, Lőrinc Polivka, Mihály Pálosi, János Szlávik, György Rokszin, Cecília Müller, Zoltán Szekanecz, Miklós Kásler
medRxiv 2022.04.14.22273898; doi: https://doi.org/10.1101/2022.04.14.22273898
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2646)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)